Methocarbamol: Effect on Postoperative Pain Following Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

Background and Review of Literature: Laparoscopically assisted vaginal hysterectomy (LAVH) is a minimally invasive surgical procedure commonly performed to remove the uterus. While the LAVH technique offers many advantages, management of perioperative pain continues to be a concern. Methocarbamol, a centrally acting antispasmodic, has gained popularity by many anesthesia providers as a multi-modal pain adjunct. Purpose: This project was developed to evaluate the effect of intraoperative methocarbamol administration on post operative pain scores in patients undergoing an LAVH procedure. Methods: A retrospective chart review of patients who underwent an LAVH procedure was performed to analyze and compare postoperative pain scores between patients who received methocarbamol intraoperatively to those who did not receive methocarbamol. Implementation: The medication administration record (MAR) of 80 patients was reviewed to determine if the patient received methocarbamol intraoperatively. Intraoperative and postoperative opioid administration were recorded separately. A two-sample t-test was utilized to compute significance of total opioid consumption and average post anesthesia care unit (PACU) pain scores between the two groups. Results: The total intraoperative and postoperative opioid consumption between the methocarbamol (+) and methocarbamol (-) groups revealed no significance. Patients who received 1000 mg of methocarbamol intraoperatively had significantly lower pain scores at the 5, 15, and 30-minute time intervals (p=0.03, p=0.01, p=0.03) in the PACU.

Creator

• Grubbs, Carlie

Language

• English

Palabra Clave

• laparoscopic assisted vaginal hysterectomy (LAVH)
• methocarbamol
• pain

Date created

• 2024

Resource type

• Research Paper

Rights statement

• http://rightsstatements.org/vocab/InC/1.0/